GlycoMimetics, Inc. - stock earnings
GLYC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -9.2 million USD | ? USD |
| 2023Q2 | -8.3 million USD | ? USD |
| 2023Q1 | -9.8 million USD | ? USD |
| 2022Q4 | -29.2 million USD | 75 USD |
| 2022Q3 | -8.3 million USD | ? USD |
| 2022Q2 | -13.2 million USD | 75000 USD |
| 2022Q1 | -14.6 million USD | ? USD |
| 2021Q4 | -17.4 million USD | 18000 USD |
| 2021Q3 | -17.3 million USD | 86560 USD |
| 2021Q2 | -14.4 million USD | 142 USD |
| 2021Q1 | -14.3 million USD | 1.1 million USD |
| 2020Q4 | -15.6 million USD | 163000 USD |
| 2020Q3 | -13.7 million USD | 1.0 million USD |
| 2020Q2 | -14.1 million USD | ? USD |
| 2020Q1 | -7.7 million USD | 9.0 million USD |
| 2019Q4 | -14.7 million USD | ? USD |
| 2019Q3 | -13.3 million USD | ? USD |
| 2019Q2 | -15.8 million USD | ? USD |
| 2019Q1 | -14.1 million USD | ? USD |
| 2018Q4 | -13.9 million USD | ? USD |
| 2018Q3 | -11.6 million USD | ? USD |
| 2018Q2 | -11.3 million USD | ? USD |
| 2018Q1 | -11.5 million USD | ? USD |
| 2017Q4 | -9.3 million USD | ? USD |
| 2017Q3 | -8.0 million USD | ? USD |
| 2017Q2 | -8.1 million USD | ? USD |
| 2017Q1 | -7.9 million USD | ? USD |
| 2016Q4 | -8.3 million USD | -500 USD |
| 2016Q3 | -7.9 million USD | 18500 USD |
| 2016Q2 | -8.1 million USD | ? USD |
| 2016Q1 | -7.6 million USD | ? USD |
| 2015Q4 | -8.9 million USD | 35000 USD |
| 2015Q3 | -7.2 million USD | 20.0 million USD |
| 2015Q2 | 10.4 million USD | 20.0 million USD |
| 2015Q1 | -7.1 million USD | ? USD |
| 2014Q4 | -7.4 million USD | -4 USD |
| 2014Q3 | -6.6 million USD | 15.0 million USD |
| 2014Q2 | 8.0 million USD | 15.0 million USD |
| 2014Q1 | -5.1 million USD | 23.6 million USD |
| 2013Q4 | -3.9 million USD | 77413 USD |
| 2013Q3 | -3.7 million USD | 52571 USD |
| 2013Q2 | -3.5 million USD | 55074 USD |
| 2013Q1 | 459687 USD | 3.8 million USD |
| 2012Q4 | 638029 USD | 3.9 million USD |
| 2012Q3 | 822618 USD | 3.8 million USD |
| 2011Q4 | ? USD | 3.8 million USD |
GLYC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -38.1 million USD | ? USD |
| 2022 | -93.3 million USD | 74925 USD |
| 2021 | -63.1 million USD | 1.2 million USD |
| 2020 | -50.3 million USD | 10.2 million USD |
| 2019 | -54.1 million USD | 9.0 million USD |
| 2018 | -48.3 million USD | ? USD |
| 2017 | -33.3 million USD | ? USD |
| 2016 | -31.8 million USD | 18000 USD |
| 2015 | -12.8 million USD | 20.1 million USD |
| 2014 | -11.1 million USD | 15.0 million USD |
| 2013 | -10.6 million USD | 4.0 million USD |
| 2012 | 3.7 million USD | 15.3 million USD |
| 2011 | -6.1 million USD | 3.8 million USD |
GLYC
Price: $1.64
52 week price:
Earnings Per Share: -0.63 USD
P/E Ratio: -5.08
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Ebitda: -8.1 millionMarket Capitalization: 178.0 million